Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 26, 2013
Grant Date -
Jul 8, 2010
app pub date -
Mar 22, 2010
filing date -
Jun 17, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully